Clinical Efficacy of Modified Weijingtang and Maxing Shigan Tang Combined with Half-dose Hormones on Refractory Mycoplcasma Pneumoniae Pneumonia in Children Caused by Toxic Heat Closing Lung

Shu-ling WANG; Jiang-hong HOU; Yan ZHANG; Yan-rong GUO; Fang LI

doi:10.13422/j.cnki.syfjx.20201021

您当前的位置：

首页 >

文章列表页 >

Clinical Efficacy of Modified Weijingtang and Maxing Shigan Tang Combined with Half-dose Hormones on Refractory Mycoplcasma Pneumoniae Pneumonia in Children Caused by Toxic Heat Closing Lung

Clinic | 更新时间：2021-02-09

- Clinical Efficacy of Modified Weijingtang and Maxing Shigan Tang Combined with Half-dose Hormones on Refractory Mycoplcasma Pneumoniae Pneumonia in Children Caused by Toxic Heat Closing Lung
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 10, Pages: 69-74(2020)
- 作者机构：
  
  1.河南省中医院，郑州　 450002
  2.河南中医药大学　第一附属医院，郑州　 450009
  3.河南省中医药研究院，郑州　 450004
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20201021
  CLC： R22; R242; R2-031;R287
- Received：17 September 2019，
  
  Published Online：07 February 2020，
  
  Published：20 May 2020
- 稿件说明：
移动端阅览
Shu-ling WANG, Jiang-hong HOU, Yan ZHANG, et al. Clinical Efficacy of Modified Weijingtang and Maxing Shigan Tang Combined with Half-dose Hormones on Refractory Mycoplcasma Pneumoniae Pneumonia in Children Caused by Toxic Heat Closing Lung[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(10): 69-74.
DOI：

Shu-ling WANG, Jiang-hong HOU, Yan ZHANG, et al. Clinical Efficacy of Modified Weijingtang and Maxing Shigan Tang Combined with Half-dose Hormones on Refractory Mycoplcasma Pneumoniae Pneumonia in Children Caused by Toxic Heat Closing Lung[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(10): 69-74. DOI： 10.13422/j.cnki.syfjx.20201021.

摘要

目的：

观察苇茎汤合麻杏石甘汤加减联合半量激素治疗儿童毒热闭肺型难治性肺炎支原体肺炎的临床疗效。

方法：

120例患儿随机分为对照组和观察组，各60例。在基础治疗基础上，对照组给予连花清瘟颗粒＋甲强尼龙(每次10 mg·kg

-1

，2次/日)，观察组给予苇茎汤合麻杏石甘汤加减＋甲强尼龙(每次10 mg·kg

-1

，1次/日)，疗程均为14 d。观察两组治疗前后肺功能指标[最大通气量(MVV)，呼气达峰时间(TPTEF)，第1秒用力呼气容积(FEV

)，呼气达峰容积(VPTEF)]，血浆心肌酶谱[肌酸激酶(CK)，肌酸激酶同工酶(CKMB)，乳酸脱氢酶(LDH)，胫丁酸脱氢酶(HBDH)]

，免疫功能[免疫球蛋白G(IgG)，免疫球蛋白M(IgM)，红细胞免疫复合物(RBC-ICR)，红细胞C3b受体(RBC-C3bR)]，炎性因子[肿瘤坏死因子-

(TNF-

)，

-干扰素(IFN-

)，白细胞介素-13(IL-13)，白细胞介素-17A(IL-17A)]，临床疗效和不良反应。

结果：

研究期间脱落4例。观察组总有效率96.6%(57/59)，高于对照组的84.2%(48/57)(

0.05)。与对照组治疗后比较，观察组MVV，TPTEF，FEV

，VPTEF，RBC-C3bR，IL-13升高(

0.05)；CK，CKMB，LDH，HBDH，IgG，IgM，RBC-ICR，TNF-

，IFN-

和IL-17A降低(

0.05)。观察组不良反应发生率低于对照组(

0.05)。

结论：

苇茎汤合麻杏石甘汤加减联合半量激素可明显改善毒热闭肺型难治性肺炎支原体肺炎患儿的肺功能，心肌酶谱，免疫功能和炎性因子水平，不良反应发生率低。

Abstract

Objective:

To observe the clinical efficacy of modified Weijingtang and Maxing Shigan Tang combined with half-dose hormones in the treatment of mycoplcasma pneumoniae pneumonia in children caused by toxic heat closing lung.

Method:

Totally 120 cases were randomly divided into control group and observation group

with 60 cases in each group. In addition to the basic therapy

control group was given Lianhua Qingwen granules + methanilone (10 mg·kg

-1

2 times/day)

while observation group was given modified Weijingtang and Maxing Shigan Tang + methanilone (10 mg·kg

-1

1 time/day) for 14 days. Lung function indicators [maximal voluntary ventilation (MVV)

time of peak tidal expiratory flow (TPTEF)

forced expiratory volume in one second (FEV

)

volume peak time expiratory flow (VPTEF)]

plasma myocardial enzyme profile [creatine kinase (CK)

creatine kinase isoenzyme (CKMB)

lactate dehydrogenase (LDH)

hydroxybutyric acid dehydrogenase (HBDH)]

immune function [immunoglobulin G (IgG)

immunoglobulin M (IgM)

erythrocyte immune complex (RBC-ICR)

erythrocyte C3b receptor (RBC-C3bR)]

inflammatory factors [tumor necrosis factor-alpha (TNF-

)

gamma-interferon (IFN-

)

interleukin-13 (IL-13)

interleukin-17A (IL-17A)]

clinical efficacy and adverse reactions were observed before and after treatment.

Result:

Four cases fell off during the study period. The total effective rate in observation group was 96.6%(57/59)

which was higher than that in control group 84.2%(48/57

0.05). Compared with control group after treatment

lung function

RBC-C3bR and IL-13 were increased in observation group (

0.05)

while myocardial enzyme spectrum

IgG

IgM

RBC-ICR

TNF-

IFN-

and IL-17A were decreased in observation group (

0.05). The incidence of adverse reactions in observation group was

lower than that in control group(

0.05).

Conclusion:

Modified Weijingtang and Maxing Shigan Tang combined with half-dose hormones can improve lung function

myocardial enzyme profile

immune function and inflammatory factor levels of refractory mycoplasma pneumoniae in children caused by toxic heat closing lung

with a incidence of adverse reactions.

关键词

Keywords

references

K WAGNER , F IMKAMP , V P PIRES , et al . Evaluation of lightmix mycoplasmamacrolide assay for detection of macrolide-resistant mycoplasma pneumoniae in pneumonia patients [J]. Clin Microbiol Infect , 2019 , 25 ( 3 ): 383.e5 - 383.e7 .

A A DAVID , L R ROCíO , C R JOSE , et al . Epidemiological and clinical analysis of community-acquired mycoplasmapneumonia in children from a spanish population, 2010-2015 [J]. Anales de Pediatría , 2019 , 91 ( 1 ): 21 - 29 .

Z YAN , C X WANG , M J ZHANG , et al . Childhood refractory mycoplasma pneumoniae pneumonia with arterial embolism: one case reported [J]. Radiol Infec Dis , 2018 , 5 ( 3 ): 135 - 137 .

N LI , Y P MU , J CHEN , et al . Value of absolute counts of lymphocyte subsets in the early prediction of refractory mycoplasma pneumoniae pneumonia in children [J]. Chin J Contemp Ped , 2019 , 21 ( 6 ): 511 - 516 .

T OKUMURA , J L KAWADA , M TANAKA , et al . Comparison of high-dose and lowdose corticosteroid therapy for refractory mycoplasma pneumoniae pneumonia in children [J]. J Infect Chemother , 2019 , 25 ( 5 ): 346 - 350 .

L Z HUANG , X HUANG , W J JIANG , et al . Independent predictors for longer radiographic resolution in patients with refractory mycoplasma pneumoniae pneumonia: a prospective cohort study [J]. BMJ Open , 2018 , 8 ( 12 ): e23719 - e23726 .

X WANG , L J ZHONG , Z M CHEN , et al . Necrotizing pneumonia caused by refractory mycoplasma pneumonia pneumonia in children [J]. World J Pediatr , 2018 , 14 ( 4 ): 344 - 349 .

J R LIU , J LU , F DONG , et al . Low bacterial coinfection invalidates the early use of nonanti mycoplasma pneumoniae antibiotics in pediatric refractory mycoplasma pneumoniae pneumonia patients [J]. Front Pediatr , 2018 , 6 ( 296 ): 3389 - 3395 .

钱亚玲 . 中西医结合治疗小儿难治性肺炎支原体肺炎 [J]. 中国实验方剂学杂志， 2011 , 17 ( 21 ): 268 - 270 .

栗守芳 . 中西医结合治疗小儿难治性肺炎支原体肺炎临床观察 [J]. 光明中医， 2019 , 34 ( 17 ): 2712 - 2713 .

胡亚美，江载芳 . 诸福棠实用儿科学 [M]. 7版 . 北京：人民卫生出版社， 2002 : 1204 - 1205 .

马融 . 中医临床诊疗指南释义(儿科疾病分册) [M]. 北京：中国中医药出版社， 2015 ： 26 - 29 .

高怡 . 肺活量和通气功能测定的技术规范与质量控制 [J]. 中华结核和呼吸杂志， 2012 , 35 ( 8 ): 630 - 632 .

中华中医药学会儿科分会 . 小儿肺炎喘嗽中医诊疗指南 [J]．中医儿科杂志， 2008 , 4 ( 3 ): 1 - 3 .

李虎年，刘杰，赵旭，等 . 难治性肺炎支原体肺炎患儿医院感染的病原菌特点及相关因素分析 [J]. 中华医院感染学杂志， 2018 , 28 ( 2 ): 273-275，283 .

姜泽群，马艳霞，陆烨，等 . 麦门冬汤合千金苇茎汤对小鼠Lewis原位肺癌lncRNA，mRNA表达谱的影响 [J]. 中国实验方剂学杂志， 2019 , 25 ( 17 ): 14 - 22 .

S ANAIS , G CAMILLE , A AUDREY , et al . Congenital pneumonia owing to mycoplasma pneumoniae [J]. J Pediatr , 2018 , 203 ( 12 ): 460 - 460 .

N DANUTA , G EWELINA , S AGATA , et al . Frequencies of PD-1-and PD-L1-positive TCD3 ＋ CD4 ＋，TCD3 ＋ CD8 ＋ and BCD19 ＋ lymphocytes and its correlations with other immune cells in patients with recurrent furunculosis [J]. Microbial Pathogenesis , 2019 , 126 ( 1 ): 85 - 91 .

Y Y XU , L X YU , C L HAO , et al . Plasma soluble B 7 -H 3 levels for severity evaluation in pediatric patients with Mycoplasma pneumoniae pneumonia [J]. Int Immunopharmacol , 2019 , 73 ( 8 ): 163 - 171 .

汤娜 . 舒血宁注射液联合糖皮质激素对慢性肾小球肾炎患者的临床疗效 [J]．中成药， 2019 , 41 ( 5 ): 1050 - 1053 .

马蕴蕾，宿英豪，于向艳 . 补肾益肺化纤方治疗慢性阻塞性肺疾病稳定期合并肺纤维化疗效及对患者肺功能及生活质量的影响 [J]. 中国实验方剂学杂志， 2018 , 24 ( 11 ): 168 - 172 .

李桂双，卜洁琼，龙剑文 . 蒺藜皂苷抑制肿瘤坏死因子 α 和干扰素 γ 诱导HaCaT细胞的炎症反应 [J]. 中国皮肤性病学杂志， 2019 , 33 ( 2 ): 131 - 137 .

丁凌辉，贾育新，成映霞，等 . 参苓白术散对脾虚湿困型溃疡性结肠炎大鼠结肠IL-13，IL-23及COX-2，CREB表达的影响 [J]. 中国实验方剂学杂志， 2018 , 24 ( 11 ): 67 - 72 .

W L CHARLES , I M ALI , W H DAVID , et al . Community-acquired pneumonia and hospital-acquired pneumonia [J]. Med Clin North Am , 2019 , 103 ( 3 ): 487 - 501 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰